Samer Shuaib, MD
Interventional Cardiology · Las Vegas, NVNPI 1720294440
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,893 of the $5,759 with a category attached, or 67.6%. 13 manufacturers reported payments, led by Medtronic at 46.2% of the total. 2025 is the largest year on record at $3,714, 3.0 times the $1,247 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in NV, where the typical reported total is $9,708.
Across 47 payments — averaging $122.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$2K
- Cardiovascular Systems Inc.$661
- Inari Medical, Inc.$163
- Bard Peripheral Vascular, Inc.$143
- Novo Nordisk$135
- plus $270 from 7 others
What the payments were for
- Travel & lodging$3,89368%
- Food & beverage$1,84932%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 16 | $2,660 |
| Abbott | 17 | $1,727 |
| Cardiovascular Systems Inc. | 2 | $661 |
| Inari Medical, Inc. | 1 | $163 |
| Bard Peripheral Vascular, Inc. | 1 | $143 |
| Novo Nordisk | 2 | $135 |
| Cvrx, Inc. | 1 | $102 |
| Shockwave Medical, Inc | 2 | $44 |
| Edwards Lifesciences | 1 | $44 |
| Cook Medical LLC | 1 | $23 |
| Amgen | 1 | $22 |
| Terumo Medical Corporation | 1 | $19 |
| Biotronik Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$1,385
- Peripheral Orbital Atherectomy System$647
- Micra$450
- FLOWTRIEVER CATHETER, S$327
- VenaSeal$237
- HawkOne$159
- Ozempic$110
- Barostim Neo System$102
How this compares
$5,759 in reported general payments places this provider in the 25th percentile of 62 interventional cardiology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Las Vegas
- Cres MirandaLas Vegas$660K
- Adrian Mercado-AlamoLas Vegas$118K
- Nayab ZafarLas Vegas$102K
- William ChuLas Vegas$75K
- Neville MistryLas Vegas$36K
- Leon VarjabedianLas Vegas$34K
- Moniz DawoodLas Vegas$29K
- Andrew LuxhojLas Vegas$22K
- Mohi AlkadriLas Vegas$20K
- John BedottoLas Vegas$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.